Literature DB >> 26632999

Association of inflammatory cytokine gene polymorphisms with inflammatory bowel disease in a Moroccan cohort.

N Senhaji1, A Serrano2, W Badre3, N Serbati1, M Karkouri4, Y Zaid5, S Nadifi1, J Martin2.   

Abstract

The purpose of this study was to investigate whether common variants in inflammatory and immune response genes influence inflammatory bowel disease (IBD) risk among Moroccan patients. Using a candidate gene approach, 10 single-nucleotide polymorphisms mapping on six genes (MIF_rs755622, TNFA_rs1800629, IL6_rs2069840, IL6R_rs2228145, IL6ST_rs2228044, IL17A (rs2275913, rs4711998, rs7747909, rs8193036, rs3819024)) were assessed in 510 subjects grouped in 199 IBD and 311 healthy controls. Genotyping was performed with the TaqMan allelic discrimination technology. The results were analyzed using PLINK software. The frequency of allele A for TNFA rs1800629 was significantly higher in ulcerative colitis (UC) patients compared with controls (30.16 vs 16.72%; P=0.0005; odds ratio (OR)=2.15; 95% confidence interval (CI)=1.39-3.32). Statistically significant association to UC was also found under dominant AA+AG vs GG (OR=1.85, 95% CI=1.07-3.21; P=0.02) and recessive models (OR=8.38; 95% CI=2.86-24.53; P=0.0001). In the same way, an association of TNFA rs1800629 variant was observed with IBD under recessive model AA vs AG+GG (OR=4.10; 95% CI=1.56-10.76; P=0.004). No evidence of significant associations was found for the remaining investigated polymorphisms. Our data suggest that TNFA gene promoter polymorphism participates in determining IBD susceptibility in Moroccan patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26632999     DOI: 10.1038/gene.2015.52

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  37 in total

1.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

2.  IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.

Authors:  D V Jovanovic; J A Di Battista; J Martel-Pelletier; F C Jolicoeur; Y He; M Zhang; F Mineau; J P Pelletier
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

3.  Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease.

Authors:  Wenyu Jiang; Jiewen Su; Xiaofei Zhang; Xiuqin Cheng; Jun Zhou; Ruihua Shi; Hongjie Zhang
Journal:  Inflamm Res       Date:  2014-08-18       Impact factor: 4.575

4.  Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR.

Authors:  M Komatsu; D Kobayashi; K Saito; D Furuya; A Yagihashi; H Araake; N Tsuji; S Sakamaki; Y Niitsu; N Watanabe
Journal:  Clin Chem       Date:  2001       Impact factor: 8.327

5.  Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease.

Authors:  E J Breese; C A Michie; S W Nicholls; S H Murch; C B Williams; P Domizio; J A Walker-Smith; T T MacDonald
Journal:  Gastroenterology       Date:  1994-06       Impact factor: 22.682

6.  Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.

Authors:  Tatsuya Ohkawara; Jun Nishihira; Hiroshi Takeda; Shuhei Hige; Mototsugu Kato; Toshiro Sugiyama; Toshihiko Iwanaga; Hideki Nakamura; Yuka Mizue; Masahiro Asaka
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

7.  The role of the Th-1 to Th-2 shift of the cytokine profiles of CD4 helper cells in the pathogenesis of autoimmune and hypercatabolic diseases.

Authors:  A Hässig; H Kremer; W X Liang; K Stampfli
Journal:  Med Hypotheses       Date:  1998-07       Impact factor: 1.538

8.  Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease.

Authors:  Agnes Vatay; László Bene; Agota Kovács; Zoltán Prohászka; Csaba Szalai; László Romics; Béla Fekete; István Karádi; George Füst
Journal:  Immunogenetics       Date:  2003-06-14       Impact factor: 2.846

9.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

Review 10.  Tumour necrosis factor gene polymorphism and disease prevalence.

Authors:  T Qidwai; F Khan
Journal:  Scand J Immunol       Date:  2011-12       Impact factor: 3.487

View more
  8 in total

1.  Association of Variants in IL6-Related Genes with Lung Cancer Risk in Moroccan Population.

Authors:  Houda Kaanane; Nezha Senhaji; Hind Berradi; Nadia Benchakroun; Abdellatif Benider; Mehdi Karkouri; Hicham El Attar; Meriem Khyatti; Sellama Nadifi
Journal:  Lung       Date:  2019-08-29       Impact factor: 2.584

2.  A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.

Authors:  Carolina Martínez-Laperche; Elena Buces; M Carmen Aguilera-Morillo; Antoni Picornell; Milagros González-Rivera; Rosa Lillo; Nazly Santos; Beatriz Martín-Antonio; Vicent Guillem; José B Nieto; Marcos González; Rafael de la Cámara; Salut Brunet; Antonio Jiménez-Velasco; Ildefonso Espigado; Carlos Vallejo; Antonia Sampol; José María Bellón; David Serrano; Mi Kwon; Jorge Gayoso; Pascual Balsalobre; Álvaro Urbano-Izpizua; Carlos Solano; David Gallardo; José Luis Díez-Martín; Juan Romo; Ismael Buño
Journal:  Blood Adv       Date:  2018-07-24

3.  High-Throughput Characterization of Blood Serum Proteomics of IBD Patients with Respect to Aging and Genetic Factors.

Authors:  Antonio F Di Narzo; Shannon E Telesco; Carrie Brodmerkel; Carmen Argmann; Lauren A Peters; Katherine Li; Brian Kidd; Joel Dudley; Judy Cho; Eric E Schadt; Andrew Kasarskis; Radu Dobrin; Ke Hao
Journal:  PLoS Genet       Date:  2017-01-27       Impact factor: 5.917

4.  Polymorphisms in oxidative pathway related genes and susceptibility to inflammatory bowel disease.

Authors:  Nezha Senhaji; Sellama Nadifi; Younes Zaid; Aurora Serrano; Daniel Arturo Leon Rodriguez; Nadia Serbati; Mehdi Karkouri; Wafaa Badre; Javier Martín
Journal:  World J Gastroenterol       Date:  2017-12-21       Impact factor: 5.742

5.  INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.

Authors:  Boris Takač; Silvio Mihaljević; Ljubica Glavaš-Obrovac; Aleksandar Kibel; Mirjana Suver-Stević; Silvija Canecki-Varžić; Marko Samardžija; Ines Rajkovac; Damir Kovač; Mario Štefanić
Journal:  Acta Clin Croat       Date:  2020-03       Impact factor: 0.780

6.  Incidence and prevalence of inflammatory bowel disease in Mexico from a nationwide cohort study in a period of 15 years (2000-2017).

Authors:  Jesús K Yamamoto-Furusho; Andrea Sarmiento-Aguilar; Joel J Toledo-Mauriño; Katya E Bozada-Gutiérrez; Francisco J Bosques-Padilla; Manuel A Martínez-Vázquez; Virgilio Marroquín-Jiménez; Rosalva García-Figueroa; Christian Jaramillo-Buendía; Rosa M Miranda-Cordero; Jesús A Valenzuela-Pérez; Yolanda Cortes-Aguilar; Janett S Jacobo-Karam; Emilio F Bermudez-Villegas
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

7.  Evidence for the butyrate metabolism as key pathway improving ulcerative colitis in both pediatric and adult patients.

Authors:  Zheng Zhou; Jiasheng Cao; Xiaoming Liu; Mingsong Li
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  The PTPN22 C1858T (R620W) functional polymorphism in inflammatory bowel disease.

Authors:  Younes Zaid; Nezha Senhaji; Fatima Zahra Bakhtaoui; Aurora Serrano; Nadia Serbati; Mehdi Karkouri; Wafaa Badre; Mounia Oudghiri; Javier Martin; Sellama Nadifi
Journal:  BMC Res Notes       Date:  2018-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.